-
2/ 2002Cefaclor sustained release tablets was approved for marketing
-
3/ 2003Zhejiang Anglikang Capsule Co., Ltd.
-
4/ 2003Cefradine was approved for marketing
-
5/ 2005Cefaclor was approved for listing
-
6/ 2006Cephalexin was approved for marketing
-
7/ 2007Cefixime capsule 100mg was approved for listing
-
8/ 2008Piperacillin sodium and tazobactam sodium for injection (1.25 g per case containing piperacillin, tazobactam 0.25 g)was approved for marketing
-
9/ 20085mg of levoamlodipine besylate tablets was approved for marketing
-
10/ 20082.5 mg of levoamlodipine besylate tablets was approved for marketing
-
11/ 2009Cefaclor granules was approved for marketing
-
12/ 2012Zhejiang Anglitai Pharmaceutical Co., Ltd. was established
-
13/ 2012Piperacillin sodium and tazobactam sodium for injection (each containing 2.5 g of piperacillin 2.0 g, tazobactam 0.5 g) was approved for marketing
-
14/ 2012Cefixime capsule 50mg was listed
-
15/ 2013Jiangsu Yuexin Pharmaceutical Co., Ltd. was established
-
17/ 2014Zhejiang Guangxiang Pharmaceutical Co., Ltd. was established
-
18/ 2016Zhejiang Angbo Biological Engineering Co., Ltd. was established
-
19/ 2017Zhejiang Kangyun Huapeng Pharmaceutical Co., Ltd. was established
-
20/ 2018Listed on the small and medium board in Shenzhen Stock Exchange